Lucence

Lucence is a genomic medicine company focused on precision medicine. It has independently developed a comprehensive set of cancer detection technologies targeting common cancers in Asia, including early screening and late-stage treatment options. Lucence's molecular diagnostics laboratory was the first to receive global accreditation. The company’s vision is to conquer cancer in a world where treatment is guided by rapid, accurate, and barrier-free detection of cancer characteristics.